Our Programs

SCIENTIFIC PRESENTATIONS

• AAN: American Academy of Neurology Annual Meeting
• April 2017
• Boston, MA
• Chemical Neuro Stimulation by FLX-787, a co-activator of TRPA1/TRPV1, for the Potential Treatment of Cramps, Spasms and Spasticity

• ASENT: American Society for Experimental NeuroTherapeutics
• March 2017
• Rockville, MD
• Human Efficacy of FLX-787, a Dual Activator of TRPV1 and TRPA1 Ion Channels, Reducing Muscle Cramp Frequency and Pain in Randomized Controlled Studies

• ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis
• February 2017
• Orlando FL
• Flex-201: A Multicenter, Randomized, Blinded Study to Evaluate the Efficacy and Tolerability of FLX-787 in MS

• SFN: Society for Neuroscience
• November 2016
• San Diego, CA
• Chemical Neuro Stimulation of TRPV1 and TRPA1 Sensory Neurons Decreases Muscle Cramps in Humans

• ASENT: American Society for Experimental NeuroTherapeutics
• March 2016
• Bethesda, MA
• Synthetic Transient Receptor Potential (TRP) Ion Channel Activators Demonstrate Efficacy in Preventing Human Muscle Cramping: A Potential New Drug Treatment for Muscle Cramps and Spasticity

• ACSM: American College of Sports Medicine Annual Meeting
• June 2016
• Boston, MA
• Etiology and Treatment of Exercise-Associated Muscle Cramps: Emerging Research

• AAN: American Academy of Neurology Annual Meeting
• April 2016
• Vancouver, BC
• Orally-administered TRPV1 and TRPA1 Activators Reduce Night Leg Cramps in a Randomized, Blinded, Placebo-Controlled, Crossover Human Trial

• ALS/MND: 26th International Symposium on Amyotrophic Lateral Sclerosis/Motor Neuron Disease
• December 2015
• Orlando, FL
• TRPV1 and TRPA1 Activators Reduce Human Muscle Cramping: A Potential New Treatment for ALS Symptoms

• SFN: Society for Neuroscience Annual Meeting
• October 2015
• Chicago, IL
• TRPV1 and TRPA1 Activators Reduce Human Muscle Cramping

• ECTRIMS: 21st Congress of the European Committee for Treatment and Research in Multiple Sclerosis
• October 2015
• Barcelona, Spain
• TRPV1 and TRPA1 Activators Reduce Muscle Cramping: A Potential New Treatment for MS Symptoms

• AAN: American Academy of Neurology Annual Meeting
• April 2015
• Washington, DC
• Afferent sensory input by orally-administered TRPV1 and TRPA1 activators inhibits electrically-induced muscle cramps in normal healthy volunteers